<SEC-DOCUMENT>0001387131-20-003130.txt : 20200324
<SEC-HEADER>0001387131-20-003130.hdr.sgml : 20200324
<ACCEPTANCE-DATETIME>20200324075318
ACCESSION NUMBER:		0001387131-20-003130
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20200320
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200324
DATE AS OF CHANGE:		20200324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TherapeuticsMD, Inc.
		CENTRAL INDEX KEY:			0000025743
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870233535
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-00100
		FILM NUMBER:		20736629

	BUSINESS ADDRESS:	
		STREET 1:		951 YAMATO ROAD, SUITE 220
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33431
		BUSINESS PHONE:		561-961-1900

	MAIL ADDRESS:	
		STREET 1:		951 YAMATO ROAD, SUITE 220
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33431

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMHN, Inc.
		DATE OF NAME CHANGE:	20090930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF ENTERPRISES INC
		DATE OF NAME CHANGE:	19970915

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF OIL CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>txmd-8k_032020.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:TXMD="http://therapeuticsmd.com/20200320">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" /></head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_TXMD_therapeuticsmd.com_20200320 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20200320_20200320 -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0000025743 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:EntityCentralIndexKey">0000025743</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-03-20to2020-03-20" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="txmd-20200320.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-03-20to2020-03-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000025743</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-20</xbrli:startDate>
        <xbrli:endDate>2020-03-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin: 0; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>UNITED STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SECURITIES AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Washington, D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>FORM <span id="xdx_90A_edei--DocumentType_c20200320__20200320_zYqHRjvR88Ya"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CURRENT REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Pursuant to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Date of Report (date of earliest event reported): <span id="xdx_901_edei--DocumentPeriodEndDate_c20200320__20200320_zNJ7Z12dJWPk"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 20, 2020</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityRegistrantName_c20200320__20200320_zfeALspmWN93"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:EntityRegistrantName">TherapeuticsMD, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Exact Name of Registrant as Specified in Its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20200320__20200320_zdqOT5wdfuTc"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityFileNumber_c20200320__20200320_zaKUOXzqhwU2"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:EntityFileNumber">001-00100</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20200320__20200320_zNtnKaLAuELe"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:EntityTaxIdentificationNumber">87-0233535</ix:nonNumeric></span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or Other Jurisdiction of Incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer Identification No.)</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_904_edei--EntityAddressPostalZipCode_c20200320__20200320_zIOUMnxWLLLf"><span id="xdx_903_edei--EntityAddressAddressLine1_c20200320__20200320_zmQkshdTc77f"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:EntityAddressAddressLine1">951 Yamato Road</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressAddressLine2_c20200320__20200320_zXARIM90llIj"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:EntityAddressAddressLine2">Suite 220</ix:nonNumeric></span></span><br /><span id="xdx_900_edei--EntityAddressCityOrTown_c20200320__20200320_zMvAGXEDxzAg"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:EntityAddressCityOrTown">Boca Raton</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20200320__20200320_zzdbGphzA9i7"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span> <span id="xdx_90B_edei--EntityAddressPostalZipCode_c20200320__20200320_zd5fc1ncYH3f"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:EntityAddressPostalZipCode">33431</ix:nonNumeric></span></b></span></td>
    </tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 12.1pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive office) (zip code)</span></td>
    </tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Registrant&#8217;s telephone number, including area code: <span id="xdx_909_edei--CityAreaCode_c20200320__20200320_zf8HfOeAfOBc"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:CityAreaCode">(561)</ix:nonNumeric></span> <span id="xdx_903_edei--LocalPhoneNumber_c20200320__20200320_z2Kg4xxuVI32"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:LocalPhoneNumber">961-1900</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityInformationFormerLegalOrRegisteredName_c20200320__20200320_zo8OECUw8qv3"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:EntityInformationFormerLegalOrRegisteredName">Not Applicable</ix:nonNumeric></span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 12.1pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Former name or former address, if changed since last report.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_90C_edei--WrittenCommunications_c20200320__20200320_zEgZ7R97ETDh"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span>&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--SolicitingMaterial_c20200320__20200320_zigq3aPOArR5"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span>&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_edei--PreCommencementTenderOffer_c20200320__20200320_znKUybqgQks5"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span>&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20200320__20200320_zJyJ94PWQCLg"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span>&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><span style="font: 10pt Times New Roman, Times, Serif">Securities registered pursuant to Section 12(b) of the Act:</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 43%; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Title of each class</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 17%; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Trading Symbol</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Name of each exchange on which registered</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--Security12bTitle_c20200320__20200320_zM4m89ss2NEa"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_906_edei--TradingSymbol_c20200320__20200320_zdmyUsx25TQb"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" name="dei:TradingSymbol">TXMD</ix:nonNumeric></span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--SecurityExchangeName_c20200320__20200320_ze6Fl1uldLC7"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">Emerging growth company &#160;&#160;&#160;&#160;<span id="xdx_906_edei--EntityEmergingGrowthCompany_c20200320__20200320_zuwdI8Lmi0u5"><ix:nonNumeric contextRef="From2020-03-20to2020-03-20" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;&#160;&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><b>&#160;Item 5.02</b></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><b>&#9;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain &#9;&#9;Officers; Compensatory
Arrangements of Certain Officers.</b></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(b)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
and effective as of March 20, 2020, each of Dr. Brian Bernick, Mr. John C.K. Milligan, IV and Mr. Nicholas Segal resigned from
the board of directors (the &#8220;Board&#8221;) of TherapeuticsMD, Inc., a Nevada corporation (the &#8220;Company&#8221;), and
any committees thereof. None of Dr. Bernick or Messrs. Milligan or Segal resigned as the result of any disagreement with the Company.
Following their resignations from the Board, Mr. Milligan, the Company&#8217;s President and Secretary, and Dr. Bernick, a Co-Founder
of the Company, will continue to serve as full-time employees of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(d)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
and effective as of March 20, 2020, the Board appointed each of Paul Bisaro and Dr. Gail Naughton as directors to fill two of
the vacancies created by the resignations of Messrs. Bernick, Milligan and Segal from the Board. Mr. Bisaro and Dr. Naughton will
serve until the Company&#8217;s 2020 Annual Meeting of Stockholders and until his or her respective successor is duly elected
or appointed or his or her earlier death or resignation. As of March 20, 2020, following the aforementioned resignations and appointments,
there were 11 authorized directors of the Company with one vacancy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Board has determined that each of Mr. Bisaro and Dr. Naughton is independent under the rules of the Nasdaq Global Select Market.
Mr. Bisaro and Dr. Naughton have not yet been appointed to any committees of the Board. As directors of the Company, Mr. Bisaro
and Dr. Naughton will each receive compensation in the same manner as the Company&#8217;s other non-employee directors, described
in the section entitled &#8220;Director Compensation&#8221; in the Company&#8217;s 2019 Definitive Proxy Statement on Schedule
14A filed with the Securities and Exchange Commission on April 30, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">There
are no arrangements or understandings between either Mr. Bisaro or Dr. Naughton and any other person pursuant to which such persons
were appointed as directors of the Company. Other than as described in this Current Report on Form 8-K, since the beginning of
the Company&#8217;s last fiscal year, the Company has not engaged in any transactions, and there are no proposed transactions,
or series of similar transactions, in which either Mr. Bisaro or Dr. Naughton was or is to be a participant and in which any related
person had a direct or indirect material interest in which the amount involved exceeds or exceeded $120,000.</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
                          7.01</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>Regulation
                                         FD Disclosure.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On March 24, 2020, the
Company issued a press release announcing the resignations of Dr. Bernick and Messrs. Milligan and Segal from the Board and the
concurrent appointments of Mr. Bisaro and Dr. Naughton to the Board. A copy of the press release is furnished as Exhibit 99.1
to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished in this Item 7.01 of this
Current Report on Form 8-K, including Exhibit 99.1 hereto, shall not be deemed to be &#8220;filed&#8221; for purposes of Section
18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such
information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be
expressly set forth by specific reference in such a filing.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
                          9.01</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>Financial
                                         Statements and Exhibits.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">(d)
<i>Exhibits</i>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Exhibit
Index</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exhibit<br />
Number</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Description
        of Exhibit</b></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex99-1.htm">99.1</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">Press
    Release from TherapeuticsMD, Inc., dated March 24, 2020, entitled &#8220;TherapeuticsMD Strengthens Board with Appointment of Industry Leaders&#8221;.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">Cover
    Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document).</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.2pt"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.2pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">THERAPEUTICSMD,
    INC.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%; padding-bottom: 1.1pt"><span style="font: 10pt Times New Roman, Times, Serif">Date:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 45%; padding-bottom: 1.1pt; padding-left: 1.1pt"><span style="font: 10pt Times New Roman, Times, Serif">March
    24, 2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; padding-bottom: 1.1pt; padding-left: 1.1pt"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%; padding-left: 1.1pt"><span style="font: 10pt Times New Roman, Times, Serif"><i>/s/
    Daniel A. Cartwright&#9;</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">Daniel
        A. Cartwright</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">Chief
        Financial Officer</span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdsKgkAQhp/Adxj2WtK2gvAyKYksRCK6XXKKJd2R2e3gI/WWrUo0DMzp/+YXIhQZbXSNDOdVmcMRm7ZWDqHEKzKaC3pFut0l4GuJN20dK+OG8Qem5Bn0zGIyU34/KJ/aYpVAPIukjGTsm2S+hGIvgv6ekrnqCo3TqgZlKiiYWtboFHfjh6N6k6GmG5xOyFaTSWA6icfzB2Q8lXCgp3oR3y3keSqCcIhAZEyPtrd5WEcNrGtsvJcd0X8GX9whSRc= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"><A HREF="txmd-8k_032020.htm">THERAPEUTICSMD, INC. 8-K</A></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><IMG SRC="txmd_logo.jpg" ALT="">&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0 0 314pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 88.9pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
IMMEDIATE RELEASE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.3pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TherapeuticsMD Strengthens Board with Appointment
of Industry Leaders<BR>
</B>&ndash; Paul Bisaro and Gail Naughton, Ph.D., Appointed as Independent Directors &ndash;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify"><B>BOCA RATON, Fla.</B> &ndash;
March 24, 2020 &ndash; On behalf of the Board of Directors of TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women&rsquo;s
healthcare company, Chairman Tommy G. Thompson today announced the appointments of Paul Bisaro and Gail Naughton, Ph.D., to the
Company&rsquo;s Board of Directors. The appointments fill two of the vacancies created by the resignations from the Board of Brian
Bernick, M.D., John C.K. Milligan, IV and Nicholas Segal. Dr. Bernick will continue to serve as a Co-Founder of TherapeuticsMD
on a full-time basis, supporting the Company&rsquo;s outreach with healthcare providers. Mr. Milligan will continue to serve as
the President of TherapeuticsMD on a full-time basis, leading the Company&rsquo;s infrastructure and critical operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&ldquo;We are very pleased to add
Paul and Gail as the newest independent directors to our Board. Each has a wealth of experience as both directors and members of
senior management at successful organizations,&rdquo; said former -Governor and Secretary of Health and Human Services, Thompson.
&ldquo;This is an exciting time in our company&rsquo;s growth and development, and we believe that Paul and Gail&rsquo;s respective
skill sets will complement our recent transformation to a commercial organization.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&ldquo;On behalf of the TherapeuticsMD
Board of Directors, I would like to thank Brian, John and Nick for their service to our company,&rdquo; said Thompson. &ldquo;Brian&rsquo;s
passion for innovation and persistence in solving patient needs are the reasons we have world-class products. Brian will continue
to serve as our Co-Founder and play a key role in our outreach to healthcare providers. John&rsquo;s commitment and can-do attitude
built the infrastructure and critical operations that our Company has today. John will continue to serve as our President and lead
our infrastructure and critical operations. Nick and his family were among our early investors and without their vision and commitment
we would not be where we are today. We are excited to welcome Paul and Gail to the TherapeuticsMD Board of Directors. Each of them
brings significant experience that we believe will activate our next stage of growth.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&ldquo;I am very pleased and honored
to be joining the TherapeuticsMD Board of Directors,&rdquo; said Mr. Bisaro. I believe TherapeuticsMD&rsquo;s portfolio of differentiated
products meets many of the significant unmet needs facing women today. In addition, I believe the Company&rsquo;s vitaCare platform
&ndash; which was created to remove the hassle and lack of visibility that patients often face when dealing with their insurance
coverage, reimbursement and supply &ndash; is a unique capability that supports TherapeuticsMD&rsquo;s patients. I look forward
to working with the Board and management team to use these assets to help our patients while continuing to focus on creating long-term
value for our shareholders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">Mr. Bisaro is an accomplished global
business leader with more than 25 years of generic and branded pharmaceutical experience, and a track record of driving company
growth through operational execution and corporate transformation. He has served as Executive Chairman of Allergan, plc (formerly
Actavis, plc), President, Chief Executive Officer and a member of the Board of Directors of Actavis (and its predecessor firm Watson
Pharmaceuticals, Inc.), Executive Chairman of Amneal Pharmaceuticals, Inc., and President, Chief Executive Officer and a member
of the Board of Directors of Impax Laboratories, Inc. until its acquisition by Amneal. He also served as President, Chief Operating
Officer and a member of the Board of Directors of Barr Pharmaceuticals, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&ldquo;I am honored and delighted
to be joining the Board of Directors of TherapeuticsMD. The directors and executives have created innovative products that are
poised to greatly enhance women&rsquo;s health and I share in their vision in continuing to develop solutions that will be transformative
to healthcare worldwide,&rdquo; said Dr. Naughton.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">Dr. Naughton is an accomplished
life sciences executive and researcher. Dr. Naughton founded two regenerative medicine companies and is the holder of more than
105 U.S. and foreign patents. She served as the Dean of the College of Business at San Diego State University from 2002-2011. Her
current venture, Histogen, is focused on the development of novel solutions based on the products of cells grown under simulated
embryonic conditions. She currently serves as Histogen&rsquo;s Chief Scientific Officer and Chief Business Development Officer
and is the inventor of its core technology. Dr. Naughton has brought several tissue engineered products to market including a product
for severe burns (TransCyte), a dermal replacement for diabetic ulcers (Dermagraft), an aesthetic dermal filler (Cosmederm/Cosmeplast)
and SkinMedica&rsquo;s TNS product for skin care. Dr. Naughton has been extensively published and is a frequent speaker in the
field of tissue engineering and regenerative medicine. In 2000, Dr. Naughton received the 27th Annual National Inventor of the
Year award by the Intellectual Property Owners Association in honor of her pioneering work in the field of tissue engineering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&ldquo;We are thankful to each of
Brian, John and Nick for their years of service on our Board and look forward to continuing to work with Brian and John as key
members of our leadership team,&rdquo; concluded TherapueticsMD Chief Executive Officer Robert G. Finizio. &ldquo;As TherapeuticsMD
looks to the future, adding two seasoned experts in Mr. Bisaro and Dr. Naughton to the Board while continuing to utilize two proven
performers in Dr. Bernick and Mr. Milligan, is an ideal scenario.&rdquo;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify"><B>About TherapeuticsMD</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">TherapeuticsMD, Inc. is an innovative,
leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed
to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus
in family planning, reproductive health, and menopause management. The Company is committed to advancing the health of women and
championing awareness of their healthcare issues. To learn more about TherapeuticsMD, please visit&nbsp;<U>www.therapeuticsmd.com</U>&nbsp;or
follow us on Twitter: @TherapeuticsMD and on Facebook: TherapeuticsMD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">This press release by TherapeuticsMD,
Inc. may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating
to TherapeuticsMD&rsquo;s objectives, plans and strategies as well as statements, other than historical facts, that address activities,
events or developments that the company intends, expects, projects, believes or anticipates will or may occur in the future. These
statements are often characterized by terminology such as &quot;believes,&quot; &quot;hopes,&quot; &quot;may,&quot; &quot;anticipates,&quot;
&quot;should,&quot; &quot;intends,&quot; &quot;plans,&quot; &quot;will,&quot; &quot;expects,&quot; &quot;estimates,&quot; &quot;projects,&quot;
&quot;positioned,&quot; &quot;strategy&quot; and similar expressions and are based on assumptions and assessments made in light
of management&rsquo;s experience and perception of historical trends, current conditions, expected future developments and other
factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release,
and the company undertakes no duty to update or revise any such statements, whether as a result of new information, future events
or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties,
many of which are outside of the company&rsquo;s control. Important factors that could cause actual results, developments and
business decisions to differ materially from forward-looking statements are described in the sections titled &quot;Risk Factors&quot;
in the company&rsquo;s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K
and Quarterly Reports on Form 10-Q, as well as reports on Form 8-K, and include the following: the effects of the COVID-19 pandemic;
the company&rsquo;s ability to maintain or increase sales of its products; the company&rsquo;s ability to develop and commercialize
IMVEXXY&reg;, ANNOVERA&reg;, BIJUVA&reg; and its hormone therapy drug candidates and obtain additional financing necessary therefor;
whether the company will be able to comply with the covenants and conditions under its term loan facility, including the conditions
to draw an additional tranche thereunder and whether the lender will make such tranche available; the potential of adverse side
effects or other safety risks that could adversely affect the commercialization of the company&rsquo;s current or future approved
products or preclude the approval of the company&rsquo;s future drug candidates; whether the FDA will approve the efficacy supplement
for the lower dose of BIJUVA; the company&rsquo;s ability to protect its intellectual property, including with respect to the
Paragraph IV notice letters the company received regarding IMVEXXY and BIJUVA; the length, cost and uncertain results of future
clinical trials; the company&rsquo;s reliance on third parties to conduct its manufacturing, research and development and clinical
trials; the ability of the company&rsquo;s licensees to commercialize and distribute the company&rsquo;s products; the ability
of the company&rsquo;s marketing contractors to market ANNOVERA; the availability of reimbursement from government authorities
and health insurance companies for the company&rsquo;s products; the impact of product liability lawsuits; the influence of extensive
and costly government regulation; the volatility of the trading price of the company&rsquo;s common stock and the concentration
of power in its stock ownership. PDF copies of the company&rsquo;s historical press releases and financial tables can be viewed
and downloaded at it website:&nbsp;<U>www.therapeuticsmd.com/pressreleases.aspx</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"># # #</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.35pt; text-indent: -5.35pt"><B><U>Investor Contact</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nichol Ochsner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Vice President, Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">561-961-1900, ext. 2088</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nochsner@TherapeuticsMD.com</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U></U></FONT></P>



<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>txmd_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 txmd_logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  R 9 # 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^GK_@JO\
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M LTB^=,%B0%F KW+]OS]L/\ 9#_8O^'_ ()^(7[8NFKJ/A+Q)XNNO"OA9O\
MA6$_Q1FM/$3Z1<ZK<B+3;?2M3?3(YM.L)%DODCB27;'!([$**\O Y=B\MSW
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M<+Z?XE^4CZ3JO27Y(_@G_P"#:?\ Y25?M*?]BO\ $_\ ]6'K5?WI#JW^\O\
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M/#/BOXH>,397&G:KXVU;7=:/V3P[H-_>)I%A)K=C:);+Y4]\WZDZ%_P:D?\
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M[M+9P\4$JH8U&Q2O]=W_  20(_X=@_L%^_[+GPB ^I\+:</T/7TK^8[]F?\
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M3E:BYP2^+ZY^)W_!+#_@GA\5_AWJ?PZ\1?L@_ /1M"U'2[C2[?4_ ?PR\(>
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MXWVWUJ&)PDL)B(X2K2KVM6I3H1M3GJTERMN2YG\3XR8W(\=]'3Q(KY!A?J.
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M++P_X?TZ%T<P6&GQI;H\LI_>7-Y<[6NKZ[E/FW-W)+-+^\E;/\\__!20L?\
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MQ';*T,NH>,?!WB;PUJ6D2ZA.4C,FJ>%[;2=)O7\VYM]-MHY8X5_MC=<(H/\
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MA&UMK/P2Q\!S1V]QX(^%'@-K.RDTC2=0TVVG\07&D6L 2733>WE]_4M^V_\
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A==7W7F.3J?I_A4M%%8/_ "_)'<_C_P"W?\@HHHI#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>txmd-20200320.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6spw7xRiXhun8uCbn1MSaSAebP9w5dzielBtm97Hfn6XyklIJBe1idjuPY2sTMB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:TXMD="http://therapeuticsmd.com/20200320" elementFormDefault="qualified" targetNamespace="http://therapeuticsmd.com/20200320">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://therapeuticsmd.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="txmd-20200320_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="txmd-20200320_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>txmd-20200320_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://therapeuticsmd.com/role/Cover" xlink:href="txmd-20200320.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://therapeuticsmd.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>txmd-20200320_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US">Entity Information, Former Legal or Registered Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>7
<FILENAME>0001387131-20-003130-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001387131-20-003130-xbrl.zip
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M#2P4!P=G$G,5:V13H:Y)Q4$&/U=L<9&7[*^.,MW.[LY+\6YP,^ 'H3^%#5#
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M#97S^K_ [86D3#[4]$^S$O:+^$ O7A64JL&;+I<9R7N(C";2KL2#+7!L(EH
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MQ/ZLO"Z#8RV[GL=VOS:\3-(,_P!02P,$%     @ J#YX4-YP#W$V"P  C(H
M !4   !T>&UD+3(P,C P,S(P7VQA8BYX;6S-G6]/ZS@6QM^OM-_!VWFS*U%*
M0;,2S&5&W%X85<, 2[EW=G>T&KF)*1&NC9P4VF^_=A*GB>.3!%9KFQ?<WO@Y
MSN/XA^W\._WTTW9-T2L1:<+9^6AZ>#1"A$4\3MCJ?/1U,;Y8S.;S$4HSS&),
M.2/G(\9'/_WXYS\A^?/I+^,QNDH(C<_0%QZ-Y^R1_X!N\)J<H9\)(P)G7/R
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M$FR4*7/+@=UDDX6F)B >K,8 )O;:_,E5CUS,Y%@E,)VSF&Q_(3NP=2V=6S(
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M^J9K^4ENUIODKR5.B=SR7U!+ P04    " "H/GA0>.?I@GH'  #V6@  %0
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M7F[JQGJM%NBU"VYZ0&-,V_EVD&$2Z0JLT?VYWJJL-\[JO;FMWN&A@S:%B?"
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M 'R"H(@S'3M,8D7.!KA? _Q1+!+J>SV'0QAGQ"8P*9M*!:&*4Y/X>L(Z5T$
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M^TTW"I<;>Y>50>^TI7]1Y/A_4$L! A0#%     @ J#YX4&9&Y*< %   %$0
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J  !T>&UD+3AK7S S,C R,"YH=&U02P4&      4 !0 ] 0  WD(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>10
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "txmd-8k_032020.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "txmd-8k_032020.htm"
     ]
    },
    "labelLink": {
     "local": [
      "txmd-20200320_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "txmd-20200320_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "txmd-20200320.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 60,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "TXMD",
   "nsuri": "http://therapeuticsmd.com/20200320",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "txmd-8k_032020.htm",
      "contextRef": "From2020-03-20to2020-03-20",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://therapeuticsmd.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "txmd-8k_032020.htm",
      "contextRef": "From2020-03-20to2020-03-20",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The start date of the period covered in the document, in CCYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r11": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r13": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r14": {
   "Name": "Forms 20-F, 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220 and 240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="txmd-8k_032020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://therapeuticsmd.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="txmd-8k_032020.htm">txmd-8k_032020.htm</File>
    <File>ex99-1.htm</File>
    <File>txmd-20200320.xsd</File>
    <File>txmd-20200320_lab.xml</File>
    <File>txmd-20200320_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M^L/O*NR\L3O[CXTO@FT#O^ZB_0)02P,$%     @ J#YX4)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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MA9+W2(TOO^?.8_8,]MT<W>3P*H9G=O':SM[*M$ANKLR$V(T(>$"P&9'8VK,
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MZ<&8A6#O[I5TXH\<P_?,?P!02P,$%     @ J#YX4/_ )@B]    A0(  !H
M  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<ZV200J#,!  OR)Y0%=MZ:&H
MIUZ\MOU T-6(FH3LENKOFWI10:$'+PEAP\Q DCRPD]P83:JQ% Q]IRD5BMG>
M *A0V$LZ&8O:3RKC>LG^Z&JPLFAEC1"'X17<DB&R9,D,\C(5+B\C$;RDJY%3
M 4,''^-:4HA,,&W1R0O\E='B/WI354V!=U.\>]2\43$+!&P'Q7,0*>FP?+)K
M=$U'AZS@>S'G10R/'1Y?,5'W])=9SUZ",*V'O\E$_37 ZM=E7U!+ P04
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MH%W\S<A'2NU!7PW_R?(+4$L! A0#%     @ J#YX4!\CSP/     $P(   L
M             ( !     %]R96QS+RYR96QS4$L! A0#%     @ J#YX4"?H
MAPZ"    L0   !               ( !Z0   &1O8U!R;W!S+V%P<"YX;6Q0
M2P$"% ,4    " "H/GA0.>0V;N\    K @  $0              @ &9 0
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "H/GA0F5R<(Q &  "<)P
M$P              @ &W @  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( *@^>%"? )L)M@(  %\,   8              "  ?@(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "H/GA0E9C\Z(,"  "0!@
M%               @ 'D"P  >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4
M    " "H/GA0NJ$YBM<!   R!@  #0              @ &9#@  >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( *@^>% P _>^-P$  "("   /
M  "  9L0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "H/GA0_\ F"+T
M  "% @  &@              @ '_$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " "H/GA0"X_8 R$!  !7!   $P
M@ 'T$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "@ * ( "  !&%
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>txmd-8k_032020_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="txmd-20200320.xsd" xlink:type="simple"/>
    <context id="From2020-03-20to2020-03-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000025743</identifier>
        </entity>
        <period>
            <startDate>2020-03-20</startDate>
            <endDate>2020-03-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-03-20to2020-03-20">0000025743</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-03-20to2020-03-20">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2020-03-20to2020-03-20">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-03-20to2020-03-20">2020-03-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2020-03-20to2020-03-20">TherapeuticsMD, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-03-20to2020-03-20">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2020-03-20to2020-03-20">001-00100</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-03-20to2020-03-20">87-0233535</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-03-20to2020-03-20">951 Yamato Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2020-03-20to2020-03-20">Suite 220</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2020-03-20to2020-03-20">Boca Raton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2020-03-20to2020-03-20">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2020-03-20to2020-03-20">33431</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2020-03-20to2020-03-20">(561)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-03-20to2020-03-20">961-1900</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="From2020-03-20to2020-03-20">Not Applicable</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications contextRef="From2020-03-20to2020-03-20">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2020-03-20to2020-03-20">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2020-03-20to2020-03-20">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2020-03-20to2020-03-20">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2020-03-20to2020-03-20">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-03-20to2020-03-20">TXMD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-03-20to2020-03-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-03-20to2020-03-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6605808464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 20, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 20,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-00100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TherapeuticsMD, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000025743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0233535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">951 Yamato Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boca Raton<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(561)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">961-1900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TXMD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Not Applicable<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
